Intersect ENT Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Intersect ENT (XENT) Tops Q3 EPS by 10c
November 2, 2020 7:05 AM ESTIntersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $21.8 million.
Outlook:
As previously announced, due to the continued uncertainties resulting from the... More
